Abstract | OBJECTIVE: RESEARCH METHODS AND PROCEDURES: Seven adult subjects who had problems with binge eating (mean age, 42 years) were randomly assigned to receive alternating sibutramine and placebo in a double-blind placebo-controlled crossover study. This involved two 4-week dosing periods separated by a 2-week washout. RESULTS: Subjects lost weight on sibutramine but not on placebo. There was a significant difference in the number of kilocalories consumed between the sibutramine and placebo conditions, with a significant reduction of intake during binge-eating episodes on sibutramine. DISCUSSION:
Sibutramine suppresses intake during binge-eating episodes. This effect is demonstrable in a human feeding laboratory paradigm.
|
Authors | James E Mitchell, Blake A Gosnell, James L Roerig, Martina de Zwaan, Stephen A Wonderlich, Ross D Crosby, Melissa A Burgard, Beth N Wambach |
Journal | Obesity research
(Obes Res)
Vol. 11
Issue 5
Pg. 599-602
(May 2003)
ISSN: 1071-7323 [Print] United States |
PMID | 12740447
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Appetite Depressants
- Cyclobutanes
- sibutramine
|
Topics |
- Adult
- Appetite Depressants
(pharmacology)
- Bulimia
(drug therapy)
- Cross-Over Studies
- Cyclobutanes
(pharmacology)
- Double-Blind Method
- Eating
(drug effects)
- Female
- Humans
- Hunger
(drug effects)
- Male
- Middle Aged
- Satiety Response
(drug effects)
- Weight Loss
(drug effects)
|